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Abstract Advances in high-throughput technologies
along with the curation of small-scale experiments has
aided in the construction of reference maps of the inter-
actome. These maps are critical to our understanding of
genotype-phenotype relationships and disease. However,
our knowledge of disease associated genes and the map of
the human interactome still remains incomplete. In this
study we investigate whether protein–protein interaction
networks (PPINs) constructed from either experimental or
curated data have an impact upon disease network analysis.
An integrative network-driven framework is implemented
to integrate diverse heterogeneous data including: gene-
expression, PPIN, ontology-based similarity, degree con-
nectivity and betweenness centrality measures to uncover
potential Alzhemier disease (AD) candidate genes. Two
PPINs have been selected and constructed from (1)
experimental high-throughput data and (2) literature-cu-
rated sources. Only a marginal overlap of protein pairs
between the two PPINs (305 protein pairs) was observed. A
total of 17 significant AD gene candidate genes were
identified using the literature derived PPIN compared to 20
genes using the PPIN constructed from high-throughput
data. Both approaches correctly identified the AD suscep-
tible TRAF1, a critical regulator of cerebral ischaemia–
reperfusion injury and neuronal death. Biological process
enrichment analysis revealed genes candidates from the
literature based PPIN are modulated in AD pathogenesis
such as neuron differentiation and involved in KEGG
pathways such as neurotrophin signaling pathways. Tissue
specific analysis revealed 48 % of AD gene candidates
obtained from the literature curated PPIN were expressed
in tissues where AD is observed compared to 19 % of gene
candidates extracted using the high-throughput PPIN.
Keywords Alzheimer’s disease  Protein–protein
interaction networks  Data integration  Network analysis
1 Introduction
Both physical and genetic interaction networks have been
instrumental in providing valuable insights into complex
biological systems. These insights include understanding
how different processes communicate through to knowl-
edge of protein function [4]. The advent of high-throughput
technologies along with traditional small-scale experiments
has aided in the systematic identification of pairwise pro-
tein interactions [60] [37] and protein complexes [29] [16].
Public interaction databases including: BioGRID [6],
Human Protein Reference Database (HPRD) [28], IntAct
[27], Database of Interacting Proteins (DIP) [40] and Kyoto
Encyclopedia of Genes and Genomes (KEGG) [26] store
many interaction and pathway data across diverse organ-
isms [23]. All these data have been useful as a means to
understanding the underlying mechanisms of a cell.
In particular, the construction of protein interaction
networks has been beneficial in providing insight into
protein function [29]. Protein–protein interactions (PPIs)
play an important role in biological processes. Most pro-
teins perform their functions by interacting with other
proteins. Furthermore, they aid in the formation of protein
complexes and mediate post-translational protein modifi-
cations [54]. Systematic efforts have been made over the
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past few years to map the human protein interaction
interactome [collection of all human protein–protein
interactions (PPIs)]. These have been performed using
high-throughput techniques including: yeast two-hybrid
(Y2H) [39], mass spectrometry [13, 50] and co-affinity
purification [57]. In addition with curation of small-scale
experiments and computational approaches [51], these
studies have been advantageous in increasing the coverage
of human interactome maps. Furthermore, they have
reduced interactome map biases and have been beneficial
in providing an estimate of the interactome size [42].
However, these maps still remain incomplete and noisy,
which needs to be taken into consideration when applying
these PPIs in studies [2]. Literature-curated data sets,
although richer in interactions, are prone to investigative
biases [60] as they contain more interactions for the more
explored disease proteins [56].
With the emergence of the area ‘‘network medicine’’,
further development of protein interaction maps is essen-
tial. Network medicine as described by Barabasi et al. [2]
aims to explore disease complexity through the systematic
identification of disease pathways and modules also taking
into consideration molecular relationships between phe-
notypes. Through the analysis of network topology and
network dynamics, key discoveries including identification
of novel disease genes and pathways, biomarkers and drug
targets for disease are advanced [48]. Key work in the area
include the study by Xu et al. [56] who analyzed topo-
logical features of a PPI network. This study observed that
hereditary disease-genes from the Online Mendelian
Inheritance in Man (OMIM) database [21] have a larger
degree and tendency to interact with other disease-genes in
literature curated networks. These tendencies were not
observed in networks constructed from high-throughput
experiments. Other studies such as Chuang et al. [9] and
Taylor et al. [46] have indicated that the alterations in the
physical interaction network may be an indicator of breast
cancer prognosis. The paper by Goh et al. [17] illustrated
that the majority of disease genes are nonessential and are
located in the periphery of functional networks. Research
by [14] discovered that genes connected to diseases with
similar phenotypes are more likely to interact directly with
each other. Network analysis tool such as clustering or
graph partitioning have been advantageous in uncovering
functional and potential disease modules in the interactome
[35]. The study by Vanunu et al. [49] applied a diffusion-
based method named PRINCE to prioritize genes in pros-
tate cancer, AD and type 2 diabetes.
What underpins these key research studies and future
studies is the reliance on human interactome maps which
are critical to the understanding of genotype-phenotype
relationships [37]. In this study, we aim into investigate
whether experimental data or curated data used to
construct a human protein–protein interaction network
(PPIN) has an impact upon disease network analysis.
Using our previously proposed integrative network-driven
pipeline [5] we integrate diverse heterogeneous data
including: gene-expression, PPIN, ontology-based simi-
larity, degree connectivity and betweenness centrality
measures to uncover potential disease-candidate genes. To
investigate the effect of human PPIN selection, a com-
parison of disease-gene candidates is presented when
different human PPINs are integrated into the framework.
Two PPINs have been selected for this study: (1) the
recently published proteome-scale map of the Human
Interactome Network by Rolland et al. [37] which is
referred to as PPIN_HTP and (2) a literature curated map
obtained from extracting binary PPIs from public data-
bases referred to as PPIN_LIT [51]. To illustrate PPIN
impact on disease-gene selection, Alzheimer’s disease
(AD) has been selected as a Case Study. AD is a genet-
ically complex disease whereby patients present with
progressive dementia [10]. It is the most common form of
age cognitive impairment [47]. It is characterized by the
loss of neurons along with the presence of axonal dys-
trophy, mature senile plaques and neurofibrillary tangles
[34]. Gene expression profiling studies have been suc-
cessful in identifying AD affected pathways across dif-
ferent brain areas and tissues including: mitochondrial
function, intracellular signaling and neuroinflammation
[10]. To evaluate the impact of PPIN selection on the
disease-gene selection process we perform biological
process enrichment analysis and compare the candidate
gene list to a manually curated reference dataset of ver-
ified known and susceptible AD disease genes. Further-
more, we investigate the tissues in which AD candidate
disease-genes are expressed through incorporation of tis-
sue-specific expression data.
The remainder of the paper is organized as follows, in
Sect. 2 the integrative framework is described along with
details on datasets and PPINs used in the analysis. Sec-
tion 3 provides a summary of the results obtained and
conclusions along with future work is presented in Sect. 4.
2 Materials and methods
A comparison on the impact human PPINs has on the
identification of AD disease-candidate genes is performed
via integration of PPIN data with diverse heterogeneous
including gene expression and ontology similarity mea-
sures. This framework is illustrated in Fig. 1 and detailed
in [5]. A literature curated PPIN is obtained by extracting
binary interactions from public databases. A PPIN con-
structed from high-throughput Y2H experiments is
obtained from [37].
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2.1 Identification of disease genes
Human AD gene expression data was obtained from the
Gene Expression Omnibus (GEO) database. (http://www.
ncbi.nlm.nih.gov/geo/). The selected profile GSE4757 was
generated using the platform GPL570: Affymetrix Human
Genome U133 Plus 2.0 Array. The study by Dunckley et al.
[11] examined the transcriptome of entorhinal neurons
from six cortical areas with or without neurofibrillary
tangles (a histopathology feature of AD) using Laser cap-
ture microdissection. The dataset consists of gene expres-
sion profiles of NFT-bearing entorhinal cortex neurons
from 10 mid-stage AD patients (Disease) compared with 10
histopathologically normal neurons (Control) from the
same patients and brain region. These represent the dif-
ferent stages of AD according to the pattern of disease
spread. Using the MAS5.0 function in R the CEL files were
firstly normalized. Probes in expression profile were then
mapped to corresponding NCBI Gene IDs. The average
expression value was calculated in cases where the Gene
ID related to more than one probe resulting in 20,539
unique Gene IDs.
A total of 10,106 significant genes were obtained using
the significance analysis of microarrays (SAM) [48] tech-
nique, a regularized t test approach, using the false dis-
covery rate (FDR = 0.98). Differentially expressed (DE)
genes are genes whose expression levels are significantly
different between two groups of experiments. These may
indicate clinical markers for involvement in disease
pathology.
2.2 Human protein–protein interaction networks
2.2.1 Literature based PPIN
The PPIN_LIT was obtained from [51]. The dataset consist
of 11,045 binary human protein pairs extracted from seven
publically available databases including BioGRID [6], DIP
[40], Biomolecular Interaction Network Database (BIND)
[1], HPRD [28], InACT [27], Protein Data Bank (PDB)
[38] and Molecular INTeraction database (MINT) [7]. The
set has been filtered to remove large-scale systematic pairs
and pairs involving the products: UBC, SUMO1, SUMO2,
SUMO3, SUMO4, or NEDD8. To ensure a high level of
quality, binary pairs were further filtered on evidence,
whereby protein pairs that are only support by two or more
pieces of evidence are included.
2.2.2 High-throughput PPIN
Using the high-throughput method Y2H, the PPIN_HTP
was obtained from the systematic screening of 15,517
opening read frames (ORFs) from the platform hORFeome
v5.1 (Space II) resulting in 13,944 pairwise interactions. A
subset of interactions were validated using three assays: (1)
reconstituting membrane bound receptor complex in
mammalian cells using MAPPIT, (2) reconstituting fluo-
rescent protein in Chinese hamster ovary cells using pro-
tein-fragment complementation assay and (3) the well-
based protein nucleic acid programmable protein array
wNAPPA [37].
Fig. 1 Methodology overview
applied to generate disease
candidate genes
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2.3 Integration of PPIN and gene expression data
AD gene expression data was mapped to both the PPIN_-
LIT and PPIN_HTP via NCBI geneIDs using Cytoscape
version 3.2.1 [58]. Mapping AD expression data with the
PPIN_HTP resulted in an AD disease specific network
consisting of 5457 nodes and 10,852 protein pairs.
Applying the same approach to the PPIN_LIT resulted in
an AD disease network consisting of 4130 nodes and
12,070 protein pairs.
2.4 Identification of disease candidate genes (hubs)
From the AD disease networks, hub genes were defined
based on network topological features using Cytoscape
version 3.2.1 [58]. The disease networks are represented as
an undirected graphs, G = V, E, whereby V represents a set
of nodes (proteins) and E ¼ f u; vð Þju; v 2 Vg, the set of
edges connecting the nodes. Two topological analysis
measures were applied to the disease networks to obtain
hub genes namely (1) node degree (connectivity) and (2)
betweenness centrality.
2.4.1 Degree connectivity
Degree is a measure of the number of edges that con-
nects a node. Genes with a high degree of connectivity
within a network have large numbers of interacting
partners. In PPINs it has been observed that genes with
high degrees of connectivity are more likely to be
essential as genes. Furthermore, many interacting part-
ners in a network tend to be involved in important cel-
lular processes [2]. Based on this assumption, hub genes
for both the PPIN_LIT and PPIN_HTP were chosen by
selecting genes, which have high degree distributions as
previously applied by Taylor et al. [46]. To determine
the degree cut-off threshold for selecting hubs genes, we
applied the approach used by Rakshit et al. [36]. The
degree cut-off threshold for selecting hubs was defined
as AVGþ 2  Stdð Þ, where AVG is the average degree
across all DE genes in the PPINs and Std, the standard
deviation.
2.4.2 Betweenness centrality
Betweenness is a topological feature of a network mea-
suring information flow through the network. In biological
networks, betweenness measures the paths through which
signals can pass through the interaction network Yu et al.
[61]. Identified betweenness as an important topological
property of a network where nodes with high betweenness
control most of the information flow. Betweenness
centrality is calculated in Cytoscape. The betweenness of a
node is the number of shortest paths that pass through it. It
considers node couples such as (v1, v2) and counts the
number of shortest paths linking v1 and v2 and passing
through a node n. The value is related to the total number
of shortest paths linking v1 and v2. The betweenness
centrality Cb nð Þ of a node n is computed as follows:
Cb nð Þ ¼
X
s6¼n 6¼t
hst nð Þ=hstð Þ ð1Þ
where S and t are nodes in the network different from n, hst
denotes the number of shortest paths from S to t, and hst nð Þ
is the number of shortest paths from S to t that n lies on.
Using the node betweenness distribution, genes located in
the top 50 % are firstly selected as hub genes. For hub
genes that have high betweenness but low connectivity (i.e.
degree is less than the degree cut-off threshold), additional
filtering is applied to include only genes that are directly
connected to at least 2 highly connected nodes. A similar
approach is applied in [36].
2.4.3 Calculation of network variation of hub genes
For each hub protein in the PPIN_LIT and PPIN_HTP the
average of Pearson correlation coefficients between the
hub and each of its respective partners was calculated for
both disease and control groups. This method has previ-
ously been applied by Taylor et al. [46] to measure net-
work variations among candidate genes and their
interacting genes. To determine if interactions are varied,
the difference of AD gene expression correlations of PPIs
in disease and control samples is calculated. Gene co-
expression values were mapped to the PPIN nodes via
NCBI gene IDs. The average hub difference (AvgPCC)
off correlation [Pearson’s correlation co-efficient (PCC)]




i¼1 Di  Cið Þ
n
ð2Þ
where Di and Ci represent the correlations of a hub and its
interactors for the disease and control groups respectively
and n the number of i interactors for a given hub.
To identify genes that are significantly different between
the disease and control groups we randomly assigned the
expression data gene labels to either the disease or control
group 1000 times and recalculated the AvgPCC defined in
Eq. 2. The P values for each hub was calculated as the
frequency of the random AvgPCC being greater than the
original AvgPCC divided by 1000. A network of signifi-
cant hub genes was generated using significant cut-off
threshold of P C 0.05. P values are adjusted using Bon-
ferroni correction.
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2.4.4 Ontology based semantic similarity
Genes involved in phenotypically similar diseases are often
functionally related on the molecular level [41]. Based on
this observation, the semantic similarity between hub genes
and their interactors has been selected to analyze hub genes
based on the gene ontology (GO) [15]. The GO is a con-
trolled vocabulary describing the characteristics of gene
products. Semantic similarity measures evaluate informa-
tion two genes share. The functional similarity between
two proteins is estimated using encoded information in the
GO hierarchies. In this study Wang’s [53] measure of
similarity is applied to the Biological Process hierarchy.
This measure determines the semantic similarity of two GO
terms based on the locations of terms in the GO graph and
their semantic relations with their ancestor terms. Given a
GO term A, TA denotes the set of all its ancestor terms
including term A itself. SA tð Þ can be defined as the con-
tribution of a term t 2 TA to the semantics of A based on the
relative locations of t and A in the graph. Given GO terms
A and B respectively, the semantic similarity between
these two terms, SGO A;Bð Þ, is defined as:
SGO A;Bð Þ ¼
P
t2TA\TB SA tð Þ þ SB tð Þð ÞP
t2TA SA tð Þ þ
P
t2TB SB tð Þ
ð3Þ
As one gene may be annotated by many GO terms,
similarity between two genes Sim G1;G2ð Þ, is then calcu-
lated by taking the average semantic similarity scores for
all pairs of their associated terms. The similarity score can
range between (0,1), whereby a value closer to 1 indicates
close relatedness of the two genes in biological process.
Wang’s measure was implemented using the GOSemSim
package in R [59], taking the median semantic similarity
between a hub protein and it’s interactors.
2.5 Evaluation
To evaluate the generated list of significant hub genes,
three approaches are implemented. Firstly, functional
annotation enrichment is performed using DAVID [22] to
investigate the biological implications of the gene list.
Secondly, prioritized genes were compared to genes asso-
ciated with AD. A reference dataset containing known and
susceptible AD genes was constructed using the OMIM
‘morbid map’ table [21]. Known and recently discovered
AD susceptibility genes in detailed in the study by Lam-
beret et al. [31] were also included. This resulted in a list of
52 AD related genes. Thirdly, analysis was performed on
the integrated prioritized disease-gene candidate list using
tissue-specific gene expression to evaluate if gene candi-
dates were expressed in tissues where AD is observed
including the ‘‘whole brain’’ and prefrontal cortex.
Candidate genes were filtered using tissue-specific gene
expression data retrieved from BioGPS [55]. This dataset
contains the transcription levels of 84 human tissues and
cell lines and was processed using the method described by
Lopes et al. [32]. Furthermore, a list of 570 housekeeping
genes were also included, obtained from [12] as they are
believed to be expressed in all tissues.
3 Results and discussion
Using the proposed methodology in Sect. 2, we apply
topological, semantic similarity and functional enrichment
approaches to analyze the generated candidate AD genes
obtained from using the two different PPINs. These results
are summarized below.
3.1 Selecting differentially expressed genes
To identify significantly expressed, disease related
genes from the AD gene expression data, SAM analysis
was performed in R using the SAM 5.0 package from
[8]. A total of 10,107 significantly positive DE genes
were observed from 20,539 genes in the AD microarray
dataset using the T-statistic and two class unpaired
(disease and control) response mode. The DE genes
were used as input into the construction of the AD
specific PPINs. An overview of the top 10 DE genes is
presented in Table 1 along with the SAM score based
on the T-statistic value.
3.2 Integration of PPIN with gene expression data
Using the 10,107 significant AD genes identified from the
SAM analysis, two AD disease networks were constructed
from PPIN data described in Sect. 2. The significant genes
were mapped to the PPIN nodes via NCBI gene IDs. The
PPIN_LIT protein pairs have been derived from small-
scale studies described in literature from seven public
databases. These binary literature PPIs although high in
quality may reflect bias observed in small-scale studies.
Based solely on literature-curated binary interactions, the
interactome appears restricted to a narrow dense zone [37].
In contrast to the PPIN_LIT, protein pairs in the
PPIN_HTP were obtained from large-scale high-through-
put Y2H experimentation. Compared to the PPIN_LIT, the
study by Rolland et al. [37]. demonstrates a distributed
homogeneously of protein pairs across the interactome. An
overlap of 305 protein pairs was observed between the two
AD networks mapped using the PPIN_LIT (10,852 protein
pairs) and PPIN_HTP (12,070 protein pairs) illustrated in
Fig. 2.
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3.3 Analysis of network topology
Topological analysis was performed on the AD specific
PPIN_LIT and PPIN_HTP. An overview of the global
properties of these networks is presented in Table 2.
Studies of model organisms have observed that proteins
with high degree of connectivity tend to be encoded by
essential genes [24]. Furthermore, detection of these genes
leads to larger numbers of phenotypic outcomes compared
to genes with lower connectivity [60]. Wachi et al. [52]
observed disease gene encoding proteins in lung squamous
cell carcinoma tended to have a higher degree of
connectivity. However, not all disease genes in humans are
essential genes. Goh et al. [17] found that non-essential
disease genes tend to be tissue specific located at the
functional periphery of the interactome and do not neces-
sarily encode hubs (highly connected genes). Taking this
into consideration, we include another indicator of cen-
trality, betweenness. Both Yu et al. [61] and Joy et al. [25]
demonstrated how nodes with a low degree of centrality
but high betweenness are important in a network (i.e.
bottleneck effect).
Using these networks, degree connectivity and
betweenness centrality measures were applied to select hub
genes. Genes with a high degree of connectivity and genes
with low connectivity but high betweenness were selected
using the cut-off thresholds defined in Sect. 2. Using this
approach, Table 3 presents the number of hubs for both
PPIN_LIT and PPIN_HTP networks respectively.
Interestingly, genes such as CDC42P2, SIAH1, STX4
observed in the PPIN_LIT hub list, are enriched in GO
Biological Process terms [15] including: neuron differen-
tiation, neuron projection morphogenesis, and involved in
KEGG [45] pathways such as neurotrophin signaling
pathways and neurotransmitter transportation.
3.4 Gene ontology semantic similarity analysis
Semantic similarity was applied as a quantitative measure
of functionality similarity between gene products. The
semantic similarity between a gene hub and it’s interacting
partners was calculated using the Wang semantic similarity
approach [53] detailed in Eq. (4). The R package
GOSemSim was used to calculate the similarity between
pairs of genes. To obtain the similarity value for the hub
and all its interactors, the median similarity was taken
across all protein pairs. The semantic similarity values
obtained ranged between 0 and 1. The gene hubs were
Table 1 Overview of the top 10 differentially expressed genes obtained from the Alzheimer’s microarray dataset using SAM analysis
Gene ID Gene description Score
8347 Histone cluster 1, H2bi; histone cluster 1, H2bg; histone cluster 1, H2be; histone cluster 1, H2bf; histone cluster 1, H2bc 3.41
55604 Leucine rich repeat containing 16A 3.10
196872 Hypothetical LOC196872 2.78
25778 Dual serine/threonine and tyrosine protein kinase 2.71
283847 Coiled-coil domain containing 79 2.68
51384 Wingless-type MMTV integration site family, member 16 2.55
55471 Chromosome 2 open reading frame 56 2.52
30817 Egf-like module containing, mucin-like, hormone receptor-like 2 2.51
27067 Staufen, RNA binding protein, homolog 2 (Drosophila) 2.50
6319 Stearoyl-CoA desaturase (delta-9-desaturase) 2.47
Fig. 2 Venn diagram illustrating the overlap of protein pairs from the
AD specific PPIN_LIT and PPIN_HTP





Average degree 2.04 2.78
Maximum degree 44 88
Hub threshold cut-off 8.6 15.8
Betweenness centrality cut-off 0.017 0.007
Maximum betweenness centrality 1 1
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ranked according to their similarity scores whereby 1
represents the highest similarity and 0 the lowest. Figure 3
presents a comparison between the PPIN_LIT and
PPIN_HTP in terms of semantic similarity values obtained.
Interestingly, hub genes from the PPIN_LIT obtained
higher similarity values compared to hub genes in the
PPIN_HTP network. This may reflect the quality of the
data used to construct the PPIN_LIT, which has been
obtained from literature-curated studies. Furthermore,
interaction pairs in this network are supported by two or
more sources.
3.5 Co-expression analysis of hub genes
Using AD gene expression data integrated with the
PPIN_LIT and PPIN_HTP networks we measured the
network variation of hub genes and their interactors using
the AvgPCC equation defined in Sect. 2.4.3. For disease
and control groups, PCC values between the hubs and their
interactors were calculated. Significant hub genes were
selecting using the Bonferroni corrected cut-off threshold
of P\ 0.05. For the PPIN_LIT network, a total of 17
significant hubs were identified, using the PPIN_HTP
network, 20 were identified. No overlapping significant hub
genes were observed between the two networks. These
genes are summarized in Table 4 below.
3.6 Functional annotation enrichment
The DAVID resource [22] was applied to study the most
significant GO terms (biological processes, molecular
functions, cellular components) and KEGG pathways
associated with the hubs and significant hubs obtained
using the PPIN_LIT and PPIN_HTP networks outlined in
Table 5. Functional annotation was obtained from
extracting the most over-representative GO terms (Bio-
logical Process, Cellular Component and Molecular
Function) for the groups of genes under observation with
respect to the whole genome taken as the reference back-
ground set (P value\0.05).
Enrichment analysis of PPIN_LIT hub and significant
hub genes identified significant biological processes
including: (GO:0030182) neuron differentiation,
(GO:0048812) neuron projection morphogenesis and
(GO:0031175) neuron projection development. Significant
KEGG pathways including: (hsa04722) Neurotrophin sig-
naling pathway, (hsa04010) MAPK signaling pathway,
(hsa04630) Jak-STAT signaling pathway and (hsa05014)
Amyotrophic lateral sclerosis (ALS) signaling pathway
were observed. It was noted that fewer GO terms were
enriched across the ontologies and pathways using the hub
genes obtained from PPIN_HTP analysis. However, for
pathway analysis performed on both hub genes from the
PPIN_LIT and PPIN_HTP, the KEGG pathway (hsa05200)
pathways in cancer was found to be a highly significantly
pathway. This is interesting as recent research summarized
in [44] has shown that patients with neurodegenerative
disorders (such as AD) have a substantially lower overall
risk of developing cancer.
3.7 Reference dataset comparison
The lists of hub genes obtained from using the PPIN_LIT
and PPIN_HTP networks were compared to the reference
dataset consisting of 52 AD related genes. The hubs
PSEN1 and TRAF1 were correctly identified as an AD
susceptible genes from the list of hub genes identified using
PPIN_LIT. Mutations in PSEN1 are the most common
cause of early onset of AD. TRAF1, a critical regulator of
cerebral ischaemia–reperfusion injury and neuronal death
[33]. Interestingly, TRAF1 was also identified using the
PPIN_HTP hub proteins along with LZTS2 which has
shown associated with late onset AD [3].
3.8 Tissue analysis
Tissue specificity is an important component of network
analysis as genetic diseases often target specific tissue(s).
Table 3 Overview of
PPIN_LIT and PPIN_HTP
connectivity and bottlenecks in
identifying hub genes
Number of nodes PPIN_LIT PPIN_HTP Overlap PPIN_LIT and PPIN_HTP
High connectivity (degree) 99 68 3
High betweenness (bottlenecks) 113 116 8
Selected hub genes 99 68 3
Fig. 3 Comparison of the semantic similarity values obtained for
hubs from the PPIN_LIT and PPIN_HTP networks
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Therefore, perturbations of pathways or proteins may have
differential effects among diverse tissues [19]. Taking this
into consideration, we further analyzed the gene hubs
identified from the PPIN_LIT and PPIN_HTP to determine
if gene hubs were expressed in tissues in whereby by AD is
observed namely the whole brain and prefrontal cortex.
Using tissue specific expression data from along with
housekeeping genes we identified that 48 genes hub from
the PPIN_LIT and 13 gene hubs from PPIN_HTP were
located in the whole brain and/or the prefrontal cortex
tissues. Further analysis found that the 13 genes observed
in the tissue data from the PPIN_HTP the average GO
similarity value was 0.1 (greater than the total average of
0.087) and 3 of the hub genes were significant hub genes.
Similar analysis performed using the PPIN_LIT noted that
the 48 gene hubs observed in the tissue data had an average
GO similarity value of 0.41 (same as the total average) and
an overlap of 6 significant genes.
4 Conclusions
The development of high-throughput techniques along with
the emergence of network medicine is aiding our under-
standing of disease and the interrelatedness of disease-re-
lated genes and protein [2]. Network theory has been useful
in the study of complex neurodegenerative diseases such as
AD, Parksinson’s Disease [36] and Multiple Sclerosis [48].
In this study we have highlighted AD as a Case Study in
disease network analysis. AD is the most common neu-
rodegenerative disease. Presently, AD therapies are only
symptomatic, therefore, an important health priority is the
development of novel therapies to impede its progress [18].
The integration of PPINs along with disease datasets is an
important tool in unraveling the molecular basis of
diseases. This integration can provide identification of
genes and proteins associated with diseases, an under-
standing of disease-network properties, identification of
subnetworks, and network-based disease gene classification
[43]. However, the map of the binary human PPIN is still
incomplete. The study by Yu et al. [60] suggested that
high-throughput Y2H datasets contained more false posi-
tives compared to literature-curated datasets. Whereas,
Rolland et al. [37] observed that literature-curated PPINs
are highly biased and only cover a small portion of the
interactome.
In this study we presented an evaluation between PPINs
constructed using data obtained from experimental high
throughput experiments compared to curated data and their
affect on identifying candidate AD disease genes through
network analysis and integration. We firstly observed
limited overlap (305 protein pairs) between the AD specific
PPIN_LIT and PPIN_HTP. Furthermore, using the inte-
grative framework to identify significant AD gene candi-
dates no overlap between significant AD gene candidate
genes identified using the literature derived PPIN com-
pared to the PPIN constructed from high-throughput data
were observed. In terms of enrichment analysis, a strong
performance was observed for significant gene hubs iden-
tified using the PPIN_LIT. Compared to the PPIN_HTP, a
larger proportion of terms are enriched in both the GO and
KEGG pathways. In addition, gene candidates from the
literature based PPIN are modulated in AD pathogenesis
such as neuron differentiation and involved in KEGG
pathways such as neurotrophin signaling pathways. Inter-
estingly, the AD susceptible TRAF1 gene was identified by
both analysis using the PPIN_LIT and PPIN_HTP net-
works. Through tissue specific expression analysis we
observed that 48 % of AD gene candidates obtained from
the literature curated PPIN and 19 % of gene candidates
Table 4 List of significant hubs









Table 5 GO enrichment terms and KEGG pathways observed in enrichment analysis
Number of terms PPIN_LIT hub genes PPIN_HTP hub genes PPIN_LIT significant hub genes PPIN_HTP significant hub genes
GO biological process 627 13 258 3
GO molecular function 72 12 30 0
GO cellular component 75 5 20 4
KEGG pathways 48 2 21 0
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extracted using the high-throughput PPIN were found to be
expressed in the whole brain and prefrontal cortex tissues.
In summary, we could reason that the PPIN_LIT outper-
forms the PPIN_HTP in terms of enrichment and tissue
analysis along with reference dataset comparison. How-
ever, it is important to take into consideration the limited
availability and coverage of tissue-specific data [20] along
with the possibility that significant genes identified by the
PPIN_HTP may still be meaningful but have not been
identified due to sociological or experimental biases [37].
As more high-throughput experiments are performed
such as Y2H, the coverage of the human interactome
continues to improve. This increased coverage, quality, and
diversity of human PPIN data will provide further oppor-
tunities for the molecular characterization and under-
standing of human disease [2]. In future work we aim to
integrate the high quality binary pairs obtained from lit-
erature curation with experimental binary interaction maps
increasing the coverage of the interactome.
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